Matinas BioPharma appoints Thomas Hoover as Chief Business Officer; $412k salary, 850k options

Matinas BioPharma Holdings, Inc.

Thomas Hoover, 52, appointed Chief Business Officer effective December 6, 2021.
Initial base salary of $412,000 with target bonus up to 40% of base.
Grant of options to purchase 850,000 shares under 2013 Equity Incentive Plan.
Previously Chief Business Officer at Millendo Therapeutics (NASDAQ: TPST) and VP at Sunovion.
Newly created role to lead business development, strategic planning, and licensing.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Thomas Hoover

Chief Business Officer

MTNB · Matinas BioPharma Holdings, Inc.

Effective: 2021-12-06
Filed: December 6, 2021, 6:59 PM ET

On December 6, 2021, Matinas BioPharma Holdings, Inc. (the “Company” or “Matinas”) announced that Thomas Hoover, age 52, has been appointed as the Company’s Chief Business Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Thomas Hoover was appointed as Chief Business Officer at Matinas BioPharma Holdings, Inc..

Action: appointed
Role: Chief Business Officer

Exact text from the filing

On December 6, 2021, Matinas BioPharma Holdings, Inc. (the “Company” or “Matinas”) announced that Thomas Hoover, age 52, has been appointed as the Company’s Chief Business Officer.

View on SEC.gov

Matinas BioPharma Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-21-030522

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.